SDCBP is a 298-amino-acid protein with a molecular mass of 33 kDa, featuring two PDZ domains that mediate interactions with transmembrane proteins like syndecans, ephrins, and interleukin-5 receptor subunits . These interactions enable SDCBP to:
Facilitate cytoskeletal-membrane organization and protein trafficking .
Regulate exosome biogenesis through partnerships with syndecans and PDCD6IP .
Modulate transcription factor activation, including SMAD2/3 in TGF-β signaling and YAP1 in Hippo pathways .
SDCBP exhibits widespread tissue expression, with elevated levels in:
Cancer tissues: Strong immunohistochemical staining in lung, colorectal, and breast cancers .
Subcellular compartments: Localizes to adherens junctions, focal adhesions, and exosomes .
Preclinical studies highlight SDCBP as a target:
Recombinant human Syndecan-4 protein is typically produced using a mouse myeloma cell line, NS0-derived human Syndecan-4 protein, with a C-terminal 6-His tag . The protein is purified to a high degree, with a purity greater than 90% as determined by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining .
Recombinant Syndecan-4 is used in various research applications, including: